OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL — image 1 of 3

Product details

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL

Catalog number BNC042400-100

Price for BNC042400-100

Size / count 1x 100 µL

About this product

Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis) .Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC042400-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: Basic helix loop helix protein class B1 (bHLHB1) ; basic helix-loop-helix protein 19 (bHLHe19) ; OLIG2; Oligodendrocyte lineage transcription factor 2; Oligodendrocyte specific bHLH transcription factor 2; Oligodendrocyte transcription factor 2; Protein kinase C-binding protein 2 (PRKCBP2) ; RACK17
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: OLIG2
Gene ID: 10215
NCBI Gene ID: 176977
UniProt: Q13516
Swiss Prot: Q13516
Host: Mouse
Species Reactivity: Human
Reactivity: OLIG2
Immunogen: Recombinant fragment of human OLIG2 protein (around aa 1-141) (exact sequence is proprietary)
Target Antigen: OLIG2
Clonality: Monoclonal
Clone: OLIG2/2400
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer, Neuroscience, Transcription factors
Positive Control: THP-1 cells. Astrocytoma
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 30-40 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF405S

Frequently Asked Questions

What is the catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL?

The catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL is BNC042400-100.

What sizes are available for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL in stock?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL?

Estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL?

The safety data sheet for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF405S conjugate, 0.1mg/mL used for?

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

What host species was used to raise this antibody?

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

What is the difference between this product and a similar catalogue number?

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.